Back
Genmab AS 10K Form
Sell
28
GNMSF
Genmab AS
Last Price:
$213.00
Seasonality Move:
-1.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNMSF News And Ratings
See the #1 stock for the next 7 days that we like better than GNMSF
GNMSF Financial Statistics
Sales & Book Value
| Annual Sales: | $2.4B |
|---|---|
| Cash Flow: | $301.5M |
| Price / Cash Flow: | 14.23 |
| Annual Sales: | $75.28 |
| Price / Book: | 2.78 |
Profitability
| EPS (TTM): | 10.52380 |
|---|---|
| Net Income (TTM): | $684.3M |
| Gross Margin: | $2.4B |
| Return on Equity: | 14.86% |
| Return on Assets: | 12.66% |
Genmab AS Earnings Forecast
Key Genmab AS Financial Ratios
-
The Gross Profit Margin over the past 17 years for GNMSF is 98.63%.
-
The Selling, General & Administrative Expenses for GNMSF have been equal to 20.01% of Gross Profit Margin.
-
The Research & Development expenses have been 46.32% of Revenue.
-
The Interest Expense is 0.62% of Operating Income.
-
The Net Earning history of GNMSF is 26.42% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 15 years.
Genmab AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNMSF |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.17 |
| Quick Ratio: | 5.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.86 |
|---|---|
| Forward P/E Ratio: | 0 |